Cancer Genetics

You have full text access to this OnlineOpen article

D-PCa-2: A novel transcript highly overexpressed in human prostate and prostate cancer

  1. Bernd Weigle1,†,‡,*,
  2. Andrea Kiessling1,‡,
  3. Reinhard Ebner2,
  4. Susanne Fuessel3,
  5. Achim Temme1,
  6. Axel Meye3,
  7. Marc Schmitz1,
  8. Michael A. Rieger1,
  9. Detlef Ockert4,
  10. Manfred P. Wirth3,
  11. E. Peter Rieber1

Article first published online: 3 FEB 2004

DOI: 10.1002/ijc.20049

Issue

International Journal of Cancer

International Journal of Cancer

Volume 109, Issue 6, pages 882–892, 10 May 2004

Additional Information

How to Cite

Weigle, B., Kiessling, A., Ebner, R., Fuessel, S., Temme, A., Meye, A., Schmitz, M., Rieger, M. A., Ockert, D., Wirth, M. P. and Rieber, E. P. (2004), D-PCa-2: A novel transcript highly overexpressed in human prostate and prostate cancer. Int. J. Cancer, 109: 882–892. doi: 10.1002/ijc.20049

Author Information

  1. 1

    Institute of Immunology, Medical Faculty, Technical University Dresden, Dresden, Germany

  2. 2

    Avalon Pharmaceuticals, Germantown, MD, USA

  3. 3

    Department of Urology, Medical Faculty, Technical University of Dresden, Dresden, Germany

  4. 4

    Department of Surgery, Medical Faculty, Technical University of Dresden, Dresden, Germany

  1. †

    Fax: +49-351-4586316

  2. ‡

    The first 2 authors contributed equally to this paper.

*Institute of Immunology, Fetscherstrasse 74, 01307 Dresden, Germany

Publication History

  1. Issue published online: 11 MAR 2004
  2. Article first published online: 3 FEB 2004
  3. Manuscript Accepted: 12 NOV 2003
  4. Manuscript Revised: 6 NOV 2003
  5. Manuscript Received: 10 SEP 2003

Funded by

  • Wilhelm-Vaillant-Stiftung
  • Wilhelm-Sander-Stiftung. Grant Number: 1999.009.2

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (343K)

REFERENCES

  • 1
    Bera TK, Maitra R, Iavarone C, Salvatore G, Kumar V, Vincent JJ, Sathyanarayana BK, Duray P, Lee BK, Pastan I. PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach. Proc Natl Acad Sci USA 2002; 99: 3058–63.
  • 2
    Xu LL, Shanmugam N, Segawa T, Sesterhenn IA, McLeod DG, Moul JW, Srivastava S. A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate. Genomics 2000; 66: 257–63.
  • 3
    Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N, Isaacs WB. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 1999; 59: 5975–9.
  • 4
    Srikantan V, Zou Z, Petrovics G, Xu L, Augustus M, Davis L, Livezey JR, Connell T, Sesterhenn IA, Yoshino K, Buzard GS, Mostofi FK, et al. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc Natl Acad Sci USA 2000; 97: 12216–21.
  • 5
    Xia C, Ma W, Wang F, Hua S, Liu M. Identification of a prostate-specific G-protein coupled receptor in prostate cancer. Oncogene 2001; 20: 5903–7.
  • 6
    Reiter RE., Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, Loda M, Witte ON. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci USA 1998; 95: 1735–40.
  • 7
    Nelson PS, Gan L, Ferguson C, Moss P, Gelinas R, Hood L, Wang K. Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression. Proc Natl Acad Sci USA 1999; 96: 3114–9.
  • 8
    Qi H, Fillion C, Labrie Y, Grenier J, Fournier A, Berger L, El-Alfy M, Labrie C. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells. Cancer Res 2002; 62: 721–33.
  • 9
    Paoloni-Giacobino A, Chen H, Peitsch MC, Rossier C, Antonarakis SE. Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3. Genomics 1997; 44: 309–20.
  • 10
    Lin B, White JT, Ferguson C, Bumgarner R, Friedman C, Trask B, Ellis W, Lange P, Hood L, Nelson PS. PART-1: a novel human prostate-specific, androgen-regulated gene that maps to chromosome 5q12. Cancer Res 2000; 60: 858–63.
  • 11
    Magee JA, Araki T, Patil S, Ehrig T, True L, Humphrey PA, Catalona WJ, Watson MA, Milbrandt J. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 2001; 61: 5692–6.
  • 12
    Xu J, Kalos M, Stolk JA, Zasloff EJ, Zhang X, Houghton RL, Filho AM, Nolasco M, Badaro R, Reed SG. Identification and characterization of prostein, a novel prostate-specific protein. Cancer Res 2001; 61: 1563–8.
  • 13
    Keillor JS and Aterman K. The response of poorly differentiated prostatic tumors to staining for prostate specific antigen and prostatic acid phosphatase: a comparative study. J Urol 1987; 137: 894–6.
  • 14
    Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J, Kallioniemi O-P, Gelmann EP. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res 2000; 60: 6111–5.
  • 15
    Shen-Ong GL, Feng Y, Troyer DA. Expression profiling identifies a novel alpha-methylacyl-CoA racemase exon with fumarate hydratase homology. Cancer Res 2003; 63: 3296–301.
  • 16
    Sobin LH, Wittekind C. TNM classification of malignant tumors, 5th ed. New York: Wiley-Liss, 1997.
  • 17
    Papsidero LD, Wang MC, Valenzuela LA, Murphy GP, Chu TM. A prostate antigen in sera of prostatic cancer patients. Cancer Res 1980; 40: 2428–32.
  • 18
    Vihko P, Kontturi M, Lukkarinen O, Ervasti J, Vihko R. Screening for carcinoma of the prostate: rectal examination, and enzymatic and radioimmunologic measurements of serum acid phosphatase compared. Cancer 1985; 56: 173–7.
    Direct Link:
  • 19
    Swinnen JV, Vanderhoydonc F, Elgamal AA, Eelen M, Vercaeren I, Joniau S, Van Poppel H, Baert L, Goossens K, Heyns W, Verhoeven G. Selective activation of the fatty acid synthesis pathway in human prostate cancer. Int J Cancer 2000; 88: 176–9.
    Direct Link:
  • 20
    Breathnach R, Benoist C, O'Hare K, Gannon F, Chambon P. Ovalbumin gene: evidence for a leader sequence in mRNA and DNA sequences at the exon-intron boundaries. Proc Natl Acad Sci USA 1978; 75: 4853–7.
  • 21
    Wang Z, Lo HS, Yang H, Gere S, Hu Y, Buetow KH, Lee MP. Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. Cancer Res 2003; 63: 655–7.
  • 22
    Bera TK, Iavarone C, Kumar V, Lee S, Lee B, Pastan I. MRP9, an unusual truncated member of the ABC transporter superfamily, is highly expressed in breast cancer. Proc Natl Acad Sci USA 2002; 99: 6997–7002.
  • 23
    Bull JH, Ellison G, Patel A, Muir G, Walker M, Underwood M, Khan F, Paskins L. Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray. Br J Cancer 2001; 84: 1512–9.
  • 24
    Luo J, Duggan DJ, Chen Y, Sauvageot J, Ewing CM, Bittner ML, Trent JM, Isaacs WB. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res 2001; 61: 4683–8.
  • 25
    Ernst T, Hergenhahn M, Kenzelmann M, Cohen CD, Bonrouhi M, Weninger A, Klaren R, Grone EF, Wiesel M, Gudemann C, Kuster J, Schott W, et al. Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. Am J Pathol 2002; 160: 2169–80.
  • 26
    Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM. Delineation of prognostic biomarkers in prostate cancer. Nature 2001; 412: 822–6.
  • 27
    Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson HF, Hampton GM. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001; 61: 5974–8.
  • 28
    Xu X, Liao J, Creek KE, Pirisi L. Human keratinocytes and tumor-derived cell lines express alternatively spliced forms of transforming growth factor-alpha mRNA, encoding precursors lacking carboxyl-terminal valine residues. Oncogene 1999; 18: 5554–62.
  • 29
    Rueter, SM, Dawson TR, Emeson RB. Regulation of alternative splicing by RNA editing. Nature 1999; 399: 75–9.
  • 30
    Landsman D, Soares N, Gonzales FJ, Bustin M. Chromosomal protein HMG-17: complete human cDNA sequence and evidence for a multigene family. J Biol Chem 1986; 261: 7479–84.
  • 31
    Srikantha T, Landsmann D, Bustin M. Retropseudogenes for human chromosomal protein HMG-17. J Mol Biol 1987; 197: 405–13.
  • 32
    Strichman-Almashanu LZ, Bustin M, Landsman D. Retroposed copies of the HMG genes: a window to genome dynamics. Genome Res 2003; 13: 800–12.
  • 33
    Nanbru C, Lafon I, Audigier S, Gensac MC, Vagner S, Huez G, Prats AC. Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site. J Biol Chem 1997; 272: 32061–6.
  • 34
    Huez I, Creancier L, Audigier S, Gensac MC, Prats AC, Prats H. Two independent internal ribosome entry sites are involved in translation initiation of vascular endothelial growth factor mRNA. Mol Cell Biol 1998; 18: 6178–90.
  • 35
    Negulescu D, Leong LE, Chandy KG, Semler BL, Gutman GA. Translation initiation of a cardiac voltage-gated potassium channel by internal ribosome entry. J Biol Chem 1998; 273: 20109–13.
  • 36
    de Kok JB, Verhaegh GW, Roelofs RW, Hessels D, Kiemeney LA, Aalders TW, Swinkels DW, Schalken JA. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res 2002; 62: 2695–8.
  • 37
    Gandini O, Luci L, Stigliano A, Lucera R, Di Silverio F, Toscano V, Cardillo MR. Is DD3 a new prostate-specific gene? Anticancer Res 2003; 23: 305–8.
  • 38
    Hessels D, Klein Gunnewiek JM, van Oort I, Karthaus HF, van Leenders GJ, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003; 44: 8–15.
  • 39
    Yousef GM, Obiezu CV, Luo LY, Black MH, Diamandis EP. Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated. Cancer Res 1999; 59: 4252–6.
  • 40
    Sidiropoulos M, Chang A, Jung J, Diamandis EP. Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer. Br J Cancer 2001; 85: 393–7.
View Full Article (HTML) Get PDF (343K)